Video lectures
Upcoming public lecture(s)
  • Interdisciplinary Conference on Psychedelic Research (Harlem [Netherlands], 2020): "Introduction to the pharmacodynamics of repeated psychedelic-drug intake" (for further information: icpr2020.net).

Past universitary lectures

  • Lecture series “UCL Society for the Application of Psychedelics (UCL-SAP, London [England], 2019)” (UCL, London [UK]). Optogenetic light on psychedelic drug action (for further information: www.facebook.com)
  • Lecture series “Neuroscience in Mental Health – Psychopharmacology” (UCL, London [England], 2018): Introduction to the Neuropharmacology of serotonergic hallucinogens.
  • Lecture series “Addiction and Neuropsychopharmacology in Psychiatry” (ICL, London [England], 2017): Tolerance to serotonergic hallucinogens.


Past public lectures/presentations

  • Breaking convention (London, Univ. Greenwich [England], 2019): Using optogenetics to shine a light on the motor cortical embedding of the “psychedelic signature move” (for further information: breakingconvention.co.uk).
  • Lecture series “Amsterdam Psychedelic Research Association (APRA)” (VU Univ. Amsterdam [Netherlands], 2019): Prolonged Intake of Psychedelics: Tolerance and other Sequelae (for further information: apraresearch.wordpress.com).
  • Interdisciplinary Conference on Psychedelic Research (Amsterdam [Netherlands], 2016): Differential tolerance to hyperthermia induced by LSD and DMT is paralleled by differential desensitisation of frontocortical, but not hypothalamic serotonin 2 receptors (for further information: icpr2016.nl).
  • German Pharm-Tox Summit (Free Univ. Berlin [Germany], 2016): Differential tolerance to LSD and DMT – A matter of serotonin (5-HT) 2A receptor downregulation?
  • Psychedelics – Novel Applications for Depression (Univ. Utrecht [Netherlands], 2015): LSD and the treatment of depression (for further information: stichtingopen.nl).
  • DGPT (German association for Experimental and Clinical Pharmacology and Toxicology) conference (Univ. of Techn. Dresden [Germany], 2012): Agonist-selective internalization of the human 5-HT2A receptor.
  • World Psychedelic Forum (Basel [Switzerland], 2008): LSD as experimental antidepressant in Rats.